Market Research Blog – Page 1267 – New Product Development

Global Processed Superfruits Market Poised for Steady Growth: Projected to Reach USD 202.3 Billion by 2034

The global processed superfruits market is set to grow steadily, with a projected compound annual growth rate (CAGR) of 4.1% from 2024 to 2034. The market is expected to be valued at USD 202.3 billion by 2034. In 2024, the market’s power segment was valued at approximately USD 134.8 billion.

Superfruits, known for their high nutritional value, are often used in juices that offer greater health benefits compared to other types. According to the Food and Agriculture Organization (FAO), superfruits are characterized by their exceptional nutrient content and additional health benefits, particularly their antioxidant properties.

Key Takeaways

The market is anticipated to see substantial growth due to the rising consumer preference for antioxidant-rich superfruits.
There is a growing trend towards natural foods and beverages, with increasing demand for ready-to-eat (RTE) and ready-to-drink (RTP) products. This shift is expected to bolster market expansion.
Superfruits, with their high nutritional value and functional benefits, are being incorporated into a variety of natural food products, including food colorings and flavorings, which further supports market growth.
Superfruits are prized for their exceptional nutrient content, including vitamins, minerals, and antioxidants.
Their inclusion in various food and beverage products is driven by their health benefits, which include enhanced antioxidant capacity and overall nutritional value.
The market faces challenges related to high processing, management, and preservation costs, which can impact profitability and market growth.
Flavor inconsistencies of superfruits can also hinder their broader acceptance and application, potentially limiting market development over the forecast period.

Report Preview: https://www.futuremarketinsights.com/reports/processed-superfruits-market

Competitive Landscape of the Processed Superfruits Market:

Fragmented Market: The global processed superfruits market is highly fragmented, with numerous local and regional competitors.
Competitive Strategies: Key players in the market are adopting diverse strategies to maintain their competitive edge, including:
- Partnerships: Forming strategic alliances to enhance market reach and capabilities.
- Expansions: Entering new markets or expanding operations to capture a larger share of the market.
- Mergers and Acquisitions: Acquiring or merging with other companies to strengthen market position and resource base.
- Collaborations: Engaging in collaborative efforts with other businesses or research institutions to innovate and improve product offerings.

Key Companies in the Market

Symrise AG
SunOpta Inc.
Kerry Group plc
Agrana Beteiligungs-AG
Del Monte Pacific Limited
Ocean Spray Cranberry Inc.
PepsiCo Inc.
Dabur India Ltd.
Uren Food Group Limited
Frutarom Industries Ltd.

Processed Super fruits Market by Category

By Fruit Type, Processed Superfruits Market is Segmented as:

Apple
Grape
Acai
Pomegranate
Blueberry
Cranberry
Raspberry

By Food Sub-Segment, Processed Superfruits Market is Segmented as:

Functional Food
Dairy Products
Bakery and Confectionery
Other Food Products

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Agar Market Set for Robust Growth: Projected to Reach US$ 478.4 Million by 2033

The global agar market is set to exceed USD 292 million in 2023 and is projected to grow to USD 478.4 million by 2033, advancing at a compound annual growth rate (CAGR) of 5% over the forecast period. This growth is driven by the increasing consumer preference for natural and clean-label products, as agar, derived from seaweed, aligns well with these trends.

Agar’s natural origin and versatility make it a popular choice in various food and non-food products, as manufacturers seek cleaner ingredient lists. The market is also benefiting from ongoing technological advancements and product innovations, including improvements in extraction and processing techniques, as well as the development of new product forms.

Key developments in agar technology, such as controlled-release formulations and taste masking, are likely to further expand its applications. Additionally, agar powder’s compact and lightweight nature enhances its storage and handling efficiency, making it an economically viable option for global trade.

Key Takeaways from the Agar Market:

The global agar industry grew at a CAGR of 2.1% from 2018 to 2022.
Market size increased from USD 258.6 million in 2018 to USD 281 million in 2022.
The powder segment held 55.6% of the market share in 2022.
Food and beverage applications accounted for 34.6% of the global market.
In 2022, the United States led with 28.9% of the market share, followed by China (5.5%), India (6.7%), and Japan (4.2%).

Competitive Analysis of the Agar Market

Intense Competition: The agar market is highly competitive with several key players vying for market share.
Focus on Innovation: Major players emphasize ongoing product development and innovation to meet evolving consumer and industry demands.
R&D Investments: Significant investments are made in research and development to enhance the features, applications, and quality of agar-based products.
Product Differentiation: Companies aim to differentiate themselves through advanced product offerings and unique features.
Market Positioning: Key players leverage innovation and product improvements to maintain a competitive edge and stand out in the market.
Adaptation to Trends: Firms continuously adapt to market trends and customer preferences to ensure relevance and growth.
Strategic Development: Ongoing strategies involve expanding product portfolios and enhancing agar’s functionality to capture a larger market share.

Report Preview: https://www.futuremarketinsights.com/reports/agar-market

Key Players in the Global Market

Neogen Food Safety
HISPANAGAR
AGARMEX S.A.
INDUSTRIES ROKO S.A.
PT. Agrarindo Bogatama

Agar Market Segmentation

By Form:

Food & Beverages
- Bakery
- Confectionery
- Dairy
- Canned Meat/Poultry Products
- Beverages
- Sauces, Creams, & Dressings
- Others
Bacteriological
- Culture Media
- Microbiology
Technical Applications
- Cosmetology
- Medical Applications
Others

By Form:

Splits
Powders

Report preview: https://www.futuremarketinsights.com/reports/agar-market

About Future Market Insights (FMI)

Contact Us:

Pediatric Vaccine Market Expected to Surge to USD 184,706.7 Million by 2033 at a 13.1% of CAGR

The global pediatric vaccine market, which is valued at USD 54,130.1 million in 2023. The market is projected to expand significantly at a compound annual growth rate (CAGR) of 13.1%, reaching an estimated valuation of USD 184,706.7 million by 2033.

This impressive growth reflects increasing global awareness of vaccination’s importance in preventing childhood diseases and advancements in vaccine development. The rise in vaccine coverage and the introduction of new and improved pediatric vaccines are driving the market’s expansion.

The paediatric vaccine market is a billion-dollar market accounting for a substantial proportion of healthcare expenditure in recent times. The paediatric vaccine market is segmented according to indication, technology and vaccine type. According to the indication, the paediatric vaccine market is sub-segmented into pneumococcal, DTP, rotavirus, influenza, meningococcal, hepatitis B, Hib, MMR and polio. According to technology, the market is further segmented into live or attenuated, inactivated or killed, toxoid, conjugate, subunit and recombinant vaccines. By vaccine type, the global paediatric vaccine market is segmented into monovalent and multivalent vaccines.

A slew of routine immunisation initiatives rolled out by the government and private agencies have broadened the market for paediatric vaccines. A new wave of funds pumped into the market by different government and private players to curb the rise of child deaths across the globe has also opened a new window of opportunity for the paediatric vaccine market. As per the report of WHO (World Health Organization), global spending on immunisation soared from US$21.4 to US$26.9 per infant in 2014. The massive economic boom in some regions of the world is expediting the growth of the paediatric vaccine market.

Key Trends Influencing the Paediatric Vaccines Market:

By indication, the pneumococcal segment accounted for a higher revenue share in global paediatric vaccines as compared to other product segments. The pneumococcal segment is expected to reach a value of US$ 31.58 Bn by 2026, reflecting a CAGR of 14.4% over the forecast period. The growth of the pneumococcal segment is attributed to the increasing incidence of infectious diseases.

In terms of revenue, the Hib vaccine segment is the second most growing segment and is expected to reach a value of US$ 13.49 Bn by 2026, growing at a CAGR of 13.4%. The hepatitis B and meningococcal segments are expected to show double-digit CAGR growth in the forecast period contributing to the growth of the global paediatric vaccine market.

By technology, the conjugate segment accounted for the highest revenue share in the global paediatric vaccine market as compared to the live or attenuated segment. The conjugate segment is expected to reach a value of US$ 32.09 Bn by 2026, reflecting a CAGR of 14.8% over the forecast period. This is expected to be closely followed by the growth of pneumococcal and meningococcal vaccines in this segment
By end user, institutional health centres account for higher demand for the paediatric vaccine as compared to other end-user segments such as hospital pharmacies and retail pharmacies. The strong growth in institutional health centres can be attributed to increasing government interventions in immunisation programs to improve vaccine coverage. Institutional health centres are expected to register the highest CAGR of 13.8% over the forecast period.

Regional analysis

By region, North America is dominating the global paediatric vaccine market due to improved healthcare infrastructure in this region. The North American paediatric vaccine market is expected to be valued at US$ 20.15 Bn by 2026 growing at a CAGR of 11.0%. In addition to North America, demand for paediatric vaccines has been significantly growing in Western Europe and APEJ. APEJ is expected to grow at a CAGR of 14.9% over the forecast period and is expected to dominate the market by 2026 by generating revenue of US$ 22.69 Bn and revenues in Western Europe are anticipated to grow by 11.2%. Middle East and Africa are expected to grow at a CAGR of 12.6% and this growth is anticipated by growth government intervention for immunisation by carrying out national-level immunisation campaigns and also disease-specific immunisation campaigns.

Key players in the global paediatric vaccine market include

Indian Immunologicals,
GlaaxoSmithKline Plc.,
Pfizer Inc.,
Sanofi, Merck & Co. Inc.,
Panacea Biotec,
Zydus Cadila,
Emergent BioSolutions Inc.,
Serum Institute of India Pvt. Ltd.,
Bharat Biotech.

Key players in the field, for instance, attribute the growth of the paediatric vaccine market to the development in the research in February 2016, GSK submitted a US regulatory submission for expanding the indication of FLuLaval Quadrivalent, an influenza vaccine, for infants more than 6 months. These developments will boost the growth of the global paediatric vaccine market.

A Full Report – Overview

Market Segmentation

Technology

Live or Attenuated Vaccine
Inactivated or Killed Vaccine
Toxoid Vaccine
Conjugate Vaccine
Subunit Vaccine
Recombinant Vector Vaccine

Indication

Pneumococcal Conjugate Vaccine
DTP Vaccine
Influenza
Meningococcal Vaccine
Polio Vaccine
Rotavirus Vaccine
MMR Vaccine
Varicella Virus Vaccine

End User

Hospital Pharmacies
Retail Pharmacies
Institutional Health Centres

Vaccine Type

Monovalent Vaccines
Multivalent Vaccines

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Portable Oxygen Concentrator Market Set to Reach USD 4.3 Billion by 2034 at a 6.7% of CAGR

The global portable oxygen concentrator market is expected to achieve a valuation of USD 2.2 billion by 2024 and continue its positive trajectory, reaching an estimated USD 4.3 billion by 2034.

This growth reflects a compound annual growth rate (CAGR) of 6.7% over the forecast period, driven by increasing demand for portable oxygen solutions due to rising prevalence of respiratory conditions and advancements in medical technology. Portable oxygen concentrators are essential for improving the quality of life for individuals with chronic respiratory diseases, contributing to the market’s expansion.

The increasing demand for portable oxygen concentrators is driven by rising incidences of respiratory disorders, a growing aging population, and advancements in healthcare technology. These devices, which provide patients with greater mobility and improved quality of life, are becoming increasingly essential in both home care and clinical settings.

Manufacturers and stakeholders in the portable oxygen concentrator market can anticipate a promising decade of growth, spurred by innovation and the expanding needs of a health-conscious global population.

Portable oxygen concentrators (POCs) are crucial for providing respiratory support to those with breathing difficulties, enabling them to lead independent and active lives. These lightweight, portable devices are ideal for providing oxygen therapy in a range of settings, including homes, hospitals, and outdoor areas.

Pulse Flow Technology Dominates

Within the portable oxygen concentrator market, the pulse flow segment currently reigns supreme, holding a dominant share of approximately 67.7% (2021). These concentrators deliver bursts of oxygen synchronized with the patient’s inhalation cycle.

Patients can more easily handle portable oxygen concentrators because they are smaller than homecare oxygen concentrators. In addition to patients, mountaineers and tourists utilize POCs when they are in areas with low oxygen levels. The demand for portable oxygen concentrators is predicted to increase due to the growing number of people with respiratory conditions including chronic obstructive pulmonary disease (COPD) around the world.

The World Health Organization (WHO) reports that chronic obstructive pulmonary disease (COPD) is still the third most common cause of death globally, accounting for over 3.23 million fatalities. The disease’s patients frequently need oxygen therapy to raise blood oxygen levels and enhance the oxygen delivered to their organs, therefore portable oxygen concentrator sales are expected to grow at a healthy rate.

Portable oxygen concentrators are also used in the glassblowing industry, skin care products, and non-pressurized airplanes. Over the next ten years, this will increase demand for portable oxygen concentrators.

Similar to this, it is anticipated that the global market for oxygen concentrators would grow as a result of ongoing new product releases and approvals by top manufacturers. Top companies in the portable oxygen concentrators market are launching innovative and effective solutions to capitalize on new prospects.

Competitive Landscape:

In the portable oxygen concentrators market, manufacturers are adopting different strategies such as new product launches, mergers, acquisitions, partnerships, and strengthening of distribution channels to raise their sales and gain a competitive edge in the global market.

Instances of key developmental strategies by the industry players in the portable oxygen concentrators market are given below:

In April 2019, Inogen One G5, a light, easy portable oxygen concentrator created to provide oxygen requirements to patients, was launched by Inogen, Inc.
In October 2019, Precision Medical announced the launch of its new product, the Live Active Five portable oxygen concentrator. The product was created to help patients with chronic obstructive pulmonary disease and other respiratory diseases.

Key Companies Profiled:

Koninklijke Philips N.V.
Inogen, Inc
Chart Industries, Inc.
Resmed, Inc.
Invacare Corporation
Drive DeVilbiss Healthcare LLC
Precision Medical, Inc.
Besco Medical Co. Ltd.
Oxus America, Inc.
Foshan KeyhubElectronic Industries Co. Ltd.
O2 Concepts LLC
GCE Group

A Full Report – Overview

Key Market Segments Covered in Portable Oxygen Concentrators Industry Research:

By Product:

Continuous Flow Portable Oxygen Concentrator
Pulse Flow Portable Oxygen Concentrator

By End User:

Hospitals
Homecare
Ambulatory Surgical Centres
Travel Agents

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Central Venous Catheter Market to Reach USD 5,314.5 Million by 2033 at a 5.1% of CAGR

The global central venous catheters market is set to experience substantial growth over the next decade. According to our healthcare analysts, the market size is expected to achieve a valuation of USD 5,314.5 million by 2033, reflecting a compound annual growth rate (CAGR) of 5.1%.

Currently valued at USD 3,238.1 million in 2023, the market’s expansion is attributed to several factors, including advancements in medical technology, increasing prevalence of chronic diseases, and a rising number of surgical procedures that necessitate the use of central venous catheters.

Manufacturers in the central venous catheter industry can anticipate a steady growth trajectory, driven by continuous innovations and an increasing demand for high-quality medical devices. This growth presents lucrative opportunities for stakeholders and underscores the vital role of central venous catheters in modern healthcare.

Central venous catheters are vital to medical treatments because they allow for the administration of medications, fluids, and blood products, as well as the measurement of central venous pressure and hemodynamic monitoring. A variety of reasons, such as the growing need for minimally invasive procedures, the increasing incidence of chronic diseases, and advancements in catheter design and material, are projected to drive the growth of the central venous catheter market.

Parenteral nutrition, or intravenous nutrient infusion, is necessary for patients who are unable to acquire enough nutrients through oral or enteral means. This includes those who have had surgery, are receiving treatment for cancer, or have serious gastrointestinal disorders. As more people become aware of the significance of nutrition for both general health and patient rehabilitation, central venous catheters are becoming more and more required to deliver parenteral nutrition therapy.

Key Takeaways from the Central Venous Catheter Market Report:

In 2018, the global market size stood at US$ 2,446.9 million.
The market size developed at a 4.7% CAGR from 2018 to 2022.
In 2022, the global market size stood at US$ 3,074.7 million.
In 2022, the non-anti-microbial catheter segment garnered 75.7% of the central venous catheter market shares.
In 2022, the double lumen segment gained 63.6% of the central venous catheter market shares.
In 2022, the hospitals segment garnered 60.3% of the central venous catheter market shares.
The United Kingdom’s central venous catheter market will develop at a CAGR of 9.0% through 2033.
Germany’s central venous catheter market will rise at a 3.3% CAGR through 2033.
Australia’s central venous catheter market growth will thrive at a 5.1% CAGR through 2033.

Recent Developments Observed by FMI:

Coloplast unveiled a novel catheter in the United States in January 2023. The SpeediCath Flex Set catheter is intended for use by those with bladders and urine problems. Triple Action Coating Technology is a feature on all SpeediCath catheters designed to reduce the risk of urethral damage and urinary tract infections (UTIs) for patients with spinal cord injuries (SCI).
Braun Medical Inc. (B. Braun), a pioneer in infusion therapy, announced the launch of its new Introcan Safety 2 IV Catheter with one-time blood control in July 2022. The Introcan Safety 2 IV Catheter, the newest invention from B. Braun, makes IV access safer for the clinician by reducing the risk of blood exposure and needlestick accidents.

The CVC market is expected to continue growing as healthcare professionals strive to fulfill patients’ changing expectations and enhance clinical results. Central venous catheters are maturing into essential instruments in contemporary healthcare due to the convergence of cutting-edge technology, patient-centric design, and infection control measures. A dedication to innovation, regulatory compliance, and the search for cost-effective solutions for patients and healthcare systems underpin the market’s growth trajectory,” says an FMI analyst.

Competitive Landscape

A blend of international and regional businesses defines the central venous catheter (CVC) market’s competitive environment. Prominent multinational corporations with sizable market shares include Becton, Dickinson and Company (BD), Teleflex Inc., and C.R. Bard (now acquired by BD). These market leaders use their vast product portfolios, well-developed distribution systems, and strong R&D departments to keep a competitive edge.

Regional players are essential to supplying local markets at the same time. They frequently concentrate on specialized markets, personalization, and affordable fixes while taking into account particular regional tastes and healthcare needs. Global and regional firms frequently use partnerships, mergers, and acquisitions to increase their market share, gain access to new technology, and improve their product offerings.

Recent Developments

In January 2023, Coloplast introduced a new catheter in the United States. People with bladder and urine issues are the target market for the SpeediCath Flex Set catheter. All SpeediCath catheters have Triple Action Coating Technology, a choice for people with spinal cord injuries (SCI) and intended to lower the risk of urethral injury and urinary tract infections (UTIs).
A pioneer in infusion therapy, B. Braun Medical Inc. (B. Braun) announced the introduction of its new Introcan Safety 2 IV Catheter with one-time blood control in July 2022. The newest innovation from B. Braun makes IV access safer for the clinician by lowering the possibility of needlestick injuries and exposure to blood with the Introcan Safety 2 IV Catheter.

Key Players in the Central Venous Catheter Market:

Angio Dynamics
C.R. Bard
Teleflex Incorporated
B. Braun Melsungen AG
Kimal Healthcare
Come B.V.
Medtronic Plc
Smiths Medical
Vygon (UK) Ltd.
Becton, Dickinson, and Company
Argon Medical Devices Inc.
Boston Scientific Corporation
Cook Medical Incorporated
Medical Components Inc.
Fresenius Kabi AG

Central Venous Catheter Market Segmentation

By Product:

Dialysis Catheters
Acute Hemodialysis Catheter
Chronic Hemodialysis Catheter
Peritoneal Dialysis Catheter
PICC Catheters
Implantable Port
CVC Catheters
Tunneled Catheters
Non-tunneled Catheters

By Property:

Anti-microbial Catheter
Non-Anti-Microbial Catheter

By Design:

Single Lumen
Double Lumen
Multiple Lumen

By End-user:

Hospitals
Ambulatory Surgical Centers
Dialysis Centers
Specialty Clinics
Others

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

North American Vision Care Market to Reach USD 114,800.8 Million by 2033 at a 5.8% of CAGR

The North American vision care market, with demand expected to rise at a compound annual growth rate (CAGR) of 5.8% through 2033. The market, currently valued at USD 65,326.3 million in 2023, is projected to expand to approximately USD 114,800.8 million by the end of the forecast period.

This notable growth trajectory reflects increasing consumer awareness about eye health, advancements in vision care technology, and a rising prevalence of vision-related issues. As the population ages and the need for effective eye care solutions intensifies, the demand for comprehensive vision care products and services is set to surge.

One of the key challenges in the industry is the high costs associated with advanced vision care treatments and procedures, limiting accessibility for a significant portion of the population. Additionally, the need for more awareness regarding the importance of regular eye check-ups and preventive measures among specific demographics has contributed to the underutilization of vision care services.

The growing adoption of teleophthalmology services and the integration of digital technologies offer avenues for expanding the reach of vision care services to remote and underserved areas. The rising consumer preference for customized vision care solutions and the increasing focus on value-based care models provide opportunities for market players to innovate and diversify their product offerings.

The integration of artificial intelligence and machine learning in vision diagnostics and treatment planning has revolutionized the sector, enabling more accurate diagnoses and personalized treatment regimens. The rising adoption of wearable vision care devices and the development of advanced nanotechnology-based treatment options are also emerging as prominent trends, shaping the future of the vision care industry in North America.

“The increasing focus on eco-friendly and sustainable vision care products has gained traction, with manufacturers emphasizing the use of biodegradable materials and eco-conscious production processes,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI).

Key Takeaways from the North America Vision Care Market:

In 2023, Rx-Lenses dominate the market with a share of 47.1% in the North American vision care industry.
Retail Stores establish themselves as the foremost distribution channel in the North American vision care market, securing a significant market share of 61.2% in 2023.
Demand for vision care products in Canada exhibits a robust CAGR of 8.2%, expected to persist through 2033.
The United States showcases a vigorous demand for vision care products, with an impressive CAGR of 9.9% projected to endure until 2033.

Competition Outlook of North America Vision Care Market:

Key players operating in the vision care industry in North America compete through product diversification, technological advancements, and strategic collaborations to gain a competitive edge and expand their market share. Companies are focusing on enhancing their distribution networks and strengthening their brand presence to stay ahead in the industry.

Many leading players are investing heavily in research and development to introduce innovative products and technologies, catering to consumers’ diverse and evolving needs in the vision care sector. Strategic partnerships and mergers with local and international players enable companies to expand their geographic reach and offer comprehensive solutions to a broader customer base.

New entrants can capitalize on the growing demand for personalized and technologically advanced vision care solutions by introducing innovative products and services tailored to specific consumer segments. Investing in advanced manufacturing capabilities and distribution networks can help new players establish goodwill in the North America vision care industry.

North America Vision Care Market Recent Developments:

Alcon (Novartis) launches new PrecisionID technology for LASIK surgery. Alcon, a division of Novartis, has launched a new technology called PrecisionID for LASIK surgery. The new technology uses a laser to create a personalized 3D map of the patient’s eye, which is then used to guide the laser during surgery.
CooperVision launches new MiSight contact lenses for myopia control. CooperVision has launched a new line of contact lenses called MiSight. The new contact lenses are designed to slow the progression of myopia, or nearsightedness, in children.
Bausch & Lomb launches new ULTRA ONE DAY contact lenses. Bausch & Lomb has launched a new line of daily disposable contact lenses called ULTRA ONE DAY. The new contact lenses are designed to provide all-day comfort and moisture, and they also feature a UV filter to protect the eyes from the sun.
Warby Parker launches new Try-On program. Warby Parker, a direct-to-consumer eyewear company, has launched a new Try-On program. The new program allows customers to try on five pairs of glasses for five days at home before they buy.

Key Companies Providing North American Vision Care Market:

EssilorLuxottica
Johnson & Johnson Vision
Alcon (Novartis)
CooperVision
Bausch & Lomb
Warby Parker
LensCrafters
Visionworks
Pearle Vision
EyeBuyDirect
National Vision

A Full Report – Overview

North America Vision Care Market Key Segments:

By Product Type:

Rx-Lenses
Frames
Contact Lenses
Non-Rx Sunglasses
Reading Glasses
Contact Lens Solutions

By Distribution Channel:

Retail Stores
E-Commerce
Clinics

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Prosthetic Heart Valve Market Expected to Reach USD 27,277.6 Million by 2033 at a 7.5% of CAGR

Future Market Insights forecasts robust growth for the global prosthetic heart valve market, which is projected to reach USD 13,234.9 million by 2023. The market is anticipated to advance significantly, with a valuation of USD 27,277.6 million by 2033.

The market’s expansion is driven by a compound annual growth rate (CAGR) of 7.5% over the forecast period, fueled by the increasing prevalence of valvular heart diseases such as tricuspid regurgitation, idiopathic and ischemic mitral regurgitation, and aortic stenosis.

When considering end users, hospitals took the lead in the global prosthetic heart valve market in 2021, commanding an estimated revenue share exceeding 75%. This dominance is expected to persist throughout the forecast period

According to Future Market Insights, an increasing prevalence of valvular heart disease (VHD) is expected to augment the growth of the global prosthetic heart valve market during the forecast period. Regulatory approval for heart valves, integration of technological advancements, and an increasing number of heart valve implantation procedures are other factors expected to influence the revenue growth of the global prosthetic heart valve market in the next 10 years. However, high costs associated with transcatheter heart valve products, procedure-related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.

Segmentation highlights

The global prosthetic heart valve market is segmented on the basis of Product Type (Mechanical Heart Valves, Biological/Tissue Heart Valves, Transcatheter Heart Valves) and End User (Hospitals, Ambulatory Surgery Centres).

The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% between 2016 and 2026
The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015. Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period

Regional market projections

The global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA). The global prosthetic heart valve market is largely prominent in the developed regions.

The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%. Factors such as legislative openness and inline approval procedures are expected to contribute largely to the revenue generation potential and attractiveness of the Western Europe prosthetic heart valve market. Rising adoption of transcatheter heart valves in geriatric patients for better care is expected to fuel revenue growth in the Japan prosthetic heart valve market over the forecast period.

Vendor insights

The report on the global prosthetic heart valve market profiles some of the leading companies dominating the global prosthetic heart valve market. Top market players featured in the global prosthetic heart valve market report are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve LLC, and JenaValve Technology, Inc. Leading market players are focussing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.

Key competitors covered in terms of prosthetic heart valve market are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNovaPLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc.

Key strategies adopted by most of the major players in the global prosthetic heart valve market include:

product approvals and commercialisation, leveraging existing capabilities to create patient-centric technologies, briskly entering markets in emerging countries and offering the latest innovative technologies to healthcare facilities and, thus strengthening regional proficiency and addressing customer needs. New product launches, innovation and expansion are anticipated to form the core of these strategies during the forecast period.

A Full Report – Overview

Key Segment

By Product Type

Mechanical Heart Valves
Mechanical Aortic Valve
Mechanical Mitral Valve
Biological/Tissue Heart Valves
Tissue Aortic Valve
Tissue Mitral Valve
Transcatheter Heart Valves
Transcatheter Aortic Valve
Transcatheter Mitral Valve

By End User

Hospitals
Ambulatory Surgery Centres

About Future Market Insights (FMI)

Contact Us:

Coronary Stents Market Growth to Reach USD 51.2 Billion by 2032, Growing at a 5.1% CAGR

The fight against heart disease is gaining momentum with advancements in coronary stents. The global Coronary Stents Market is projected to reach a substantial USD 51.2 billion by 2032, reflecting a steady growth trajectory. This translates to a projected Compound Annual Growth Rate (CAGR) of 5.1% from 2022 to 2032. In 2022, the market was valued at an estimated USD 33.36 billion.

The increasing awareness of the manifold benefits associated with stenting procedures, such as the significant enhancement of blood flow and protection against further damage to the heart muscle, is a pivotal driver of market expansion. Stenting also offers a means to ameliorate heart disease symptoms, including angina and shortness of breath, ultimately reducing the necessity for coronary bypass surgery. Consequently, both surgeons and patients, given its minimally invasive nature and relatively brief post-operative recovery period, favor stenting.

Furthermore, a rise in the global geriatric population is leading to a larger patient pool with serious cardiovascular diseases. Again, hypertension is arising as a grave public health concern. Obesity, too, adds to this burden as one of the primary risk factors accountable for different cardiovascular diseases worldwide.

Coronary stenting is prescribed to patients who are suffering from coronary artery blockage. Though angioplasty is the first line of treatment for patients with acute coronary artery blockages the number of patients undergoing stenting has been increasing steadily over the last ten years. This is owing to the rise of outpatient coronary stenting procedures, which shortens long hospital stays. Additionally, a large number of cardiologists prescribing stenting procedures for patients with CAD is a prime factor that will likely fuel revenue growth of the coronary stent market during the forecast period.

“Increasing cases of lifestyle diseases like obesity and diabetes often result in heart issues which, in turn, supplements the global growth of the coronary stents market over the forecast period,” says an FMI analyst.

Coronary Stents Market Key Takeaways:

Rising awareness of the benefits associated with stenting will strengthen market prospects.
Prevalence of alternative treatment methods, product failure, and recalls are certain factors that may hamper market growth.
Growing cases of coronary artery diseases propel the coronary stent market in the United States.
Favorable government support for the healthcare sector will present new market opportunities in China.

Coronary Stents Market Competitive Landscape

Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook Medica among others are some of the major players in the coronary stents market profiled in the full version of the report.

Key market players are focusing on product upgrades and offering new features to meet the rising consumer demand. These organizations are employing strategies like new product releases, partnerships, collaborations, mergers, and acquisitions to gain a competitive advantage.

More Insights into Coronary Stents Market Report

In its latest report, FMI offers an unbiased analysis of the global coronary stents market, providing historical data from 2016 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented based on product type (drug-eluting stent (DES), bare metal stent (BMS), bioresorbable vascular stent (BVS)), raw material (cobalt chromium, stainless steel, platinum-chromium, nickel-titanium, polymer), end user (hospitals, ambulatory surgical centers, cardiac catheterization laboratories), and region.

According to the latest FMI reports, based on region, China’s coronary stent market will likely exhibit an impressive growth rate during the observation period due to favorable government support for the healthcare sector. The coronary stent market in the United States is anticipated to demonstrate substantial growth over the forecast period. The rising prevalence of coronary artery disease is spurring the demand for interventional cardiology treatment in this country. Sedentary lifestyles, smoking, poor dietary habits, and pollution often contribute to increasing cases of cardiovascular diseases. All of these factors are expected to drive the demand for the target market during 2022-2032.

Key Segments Covered in the Coronary Stents Market Analysis

By Product:

Drug Eluting Stent (DES)
Bare Metal Stent (BMS)
Bioresorbable Vascular Stent (BVS)

By Raw Material:

Cobalt-Chromium
Stainless Steel
Platinum – Chromium
Nickel – Titanium
Polymer

By End User:

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Artificial Intelligence Systems Spending Soars: Market Set to Reach US$ 516.2 Billion by 2027

The global “artificial intelligence systems spending market” is anticipated to soar with a staggering 46.1% CAGR throughout the projection period between 2017 and 2027. The coronavirus pandemic benefits from the coronavirus outbreak as businesses are remodelling operations to allow employees to work from home. Further, increased spending on online communications and cloud technologies will generate lucrative opportunities during the pandemic.

Artificial Intelligence Systems Spending Market – Key Takeaways

Banking solutions for artificial intelligence systems are gaining strong demand, owing to automated customer service, and fraud analysis applications.
Pharmaceutical research applications are likely to witness rapid growth aided by the recent spurt in growth of digital patient and formulation databases.
Asia Pacific is displaying major growth in artificial intelligence system spending, supported by investments in hardware and infrastructure for artificial intelligence development.

Artificial Intelligence Systems Spending Market – Critical Driving Factors

Growing use of artificial intelligence in ERP and manufacturing solutions and applications drive adoption rates.
Sustained automated transport and logistics investments are a key factor contributing to revenues.
Artificial Intelligence Systems Spending Market – Major Constraints

Lack of adequate infrastructure to handle vast databases, setup processes, and manage workforce remains a key challenge to market players.
High capital required for artificial intelligence system development holds back market growth.
The Anticipated Impact of Coronavirus

The covid-19 pandemic is likely to benefit the artificial intelligence systems spending market. This can be attributed to high investments in cloud and internet infrastructure, for remote working operations around the world during the pandemic. Centralization of corporate data during the crisis will help companies to build on AI capabilities.

AI systems are being used to identify and track vulnerable populations, and generate warnings for potential outbreaks in the future. Further, these systems are proving useful in administration applications in healthcare facilities. Also, increased use of online shopping. However, concerns over privacy, bias and job loss will limit gains during this period.

Competition Landscape

Prominent developers in the artificial intelligence systems spending market include but are not limited to IPsoft Inc., Google Inc., Salesforce.com Inc., Microsoft Corp., Wipro Ltd., Facebook Inc., Infosys Ltd., IBM Corp., Intel Corp., Apple Inc., and Amazon.com Inc.

Artificial intelligence systems spending market players are widely investing in strategic acquisitions to bolster their AI capabilities, and expertise in AI development workforce.

For instance, in early 2020, Apple Inc., announced the acquisition of Xnor.ai for AI-based image recognition tools. Further Amazon has announced the acquisition of Zoox, a startup focused on AI-based autonomous driving developments. Similarly, Snap has revealed its acquisition of Ukraine-based AI-Factory for developing augmented reality functionalities.

Market Taxonomy

By Industry Type :

-BFSI
-Discrete & Process Manufacturing
-Healthcare
-Retail
-Wholesale
-Professional & Consumer
-Service
-Transportation

By Technology :

-Deep Learning
-Machine Learning
-Natural Language Processing
-Machine Vision
-AGI
-ASI

By Market :

-Hardware
-Software
-Services

By Region :

-North America
-Asia-Pacific excluding
-Japan
-Western Europe
-Eastern Europe
-Latin America
-Middle East and Africa
-Japan

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Syringes and Needles Market in GCC Projected to Reach USD 1,164.90 Million by 2034 at a 5.40% of CAGR

Future Market Insights reveals that the syringes and needles market in the Gulf Cooperation Council (GCC) region is on an upward trajectory. Sales are expected to rise at a compound annual growth rate (CAGR) of 5.40% through 2034. The market is projected to surpass USD 688.5 million in 2024 and reach an estimated valuation of USD 1,164.90 million by 2034.

This growth reflects increasing healthcare demands and advancements in medical technology within the GCC region. The rising prevalence of chronic diseases, coupled with an expanding healthcare infrastructure, is driving the need for syringes and needles.

This robust growth is driven by increasing healthcare needs, rising patient volumes, and the expanding use of syringes and needles in various medical procedures. The demand for these essential medical supplies is fueled by advancements in healthcare infrastructure and a heightened focus on effective and safe medical treatments.

Digital Dentistry: The Future

In the year 2019, the IDC (International Dental Show) was attended by the Institute of Digital Dentistry in Cologne, Germany. It threw light on the ways dentistry has evolved in the form of 3D printers, CAD materials, milling machines, and intraoral scanners. The institute otherwise provides training and CAD/CAM courses in New Zealand as well as online to keep the dentists and course attendees updated about clinical relevance and implementation of digitization by the key market players.

Digital Expansion: Key to Growth

As stated above, the market players are looking to provide digital imaging solutions to cater to the increasing number of patients with dental ailments. Some of the measures taken in this regard include:

In Jun 2020, Level Equity-backed Planet DDS signed an agreement to acquire Apteryx Imaging, a Canada-based publicly traded company to explore a wider arena in terms of geography
DENTSPLY Sirona Inc., in Oct 2019, launched 2 intraoral sensors (Xios AE and Schick AE) and 3D/2D imaging systems (Orthophos E, Orthophos SL 3D, and Orthophos S 3D)
In Oct 2019, Envista Holdings Corporation entered into a partnership with TeamSmile programs all through the US for propagating the use of KaVo SMARTmatic and KaVo MASTERtorque LUX M8900L

Key Takeaways of Dental Imaging Equipment Market

The market is expected to grow steadily, reaching a value of USD 4.45 billion by 2034.
Increased focus on oral health and preventive care is driving demand for dental imaging equipment.
Patients are seeking earlier diagnosis and treatment, prompting dental practices to invest in advanced imaging technology.
Manufacturers are innovating with touchless features, remote operation, and improved disinfection to meet post-pandemic needs.

“The players are shifting their gears towards digital imaging. This upgradation is expected to shape the Global Dental Imaging Equipment Industry.” says an FMI Analyst.

More Valuable Insights on Dental Imaging Equipment Market

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2015 to 2030. The Global Dental Imaging Equipment Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights into the dental imaging equipment market based on product type, (Intraoral X-ray Systems, Intraoral Plate Scanners, Intraoral Sensors, Intraoral Phosphor Storage Plates, Extraoral X-ray Systems, Cone-Beam Computed Tomography (CBCT) Imaging, Intraoral Cameras), by End User (Hospitals, Ambulatory Surgical Centers, Independent Dental Clinics, Forensic Laboratories), across seven major regions.

Leading Players in the Dental Imaging Equipment Market

The dental imaging equipment market is onto the digital spree. Digital imaging systems are being provided by the key players to cater to the increasing number of patients throughout. At the same time, AI is being tried out as an effective tool for dental digital solutions.

In line with the above-mentioned developments, twin robotic X-Ray system from Siemens provides a combination of 2D X-Rays with fluoroscopy along with 3D imaging.

The key players in dental imaging equipment including the ones mentioned above are:

Envista Holdings Corporation
Dentsply Sirona
Carestream Dental, LLC
Danaher Corporation
Acteon Group
Planmeca Oy

Dental Imaging Equipment Market: Segmentation The Global Dental Imaging Equipment Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. Product Type

Intraoral X-ray Systems
- Wall/Floor Mounted Intraoral X-ray Systems
- Hand-Held Intraoral X-ray Systems
Intraoral Plate Scanner
Intraoral Sensors
Intraoral Phosphor Storage Plates
Extraoral X-ray Systems
- Panoramic X-rays Systems
- Cephalometric Projections Systems
Cone-Beam Computed Tomography (CBCT) Imaging
Intraoral Cameras

End Users

Hospitals
Independent Dental Clinics
Ambulatory Surgical Centres
Forensic Laboratories

A Full Report – Overview

Key Segments :

By Product:

Oral
Hypodermic
- Standard
- Special Purpose
  - Insulin
  - Tuberculin
  - Other Special Purpose
  - Angiographic

By Usability:

Disposable
Reusable

By Material:

Glass
Polymer

By End User:

Hospital
Blood Collection Center
Diabetic Care Center
Veterinary Care Center
Others

By Country:

Kingdom of Saudi Arabia (KSA)
United Arab Emirates (UAE)
Qatar
Bahrain
Oman
Kuwait

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us: